Literature DB >> 16980091

XDR-TB--a global threat.

.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16980091     DOI： 10.1016/S0140-6736(06)69391-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.

Authors:  Kanchan Ajbani; Camilla Rodrigues; Shubhada Shenai; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries.

Authors:  Cindy Maria Quezada; Eliane Kamanzi; Julienne Mukamutara; Pim De Rijk; Leen Rigouts; Françoise Portaels; Yanis Ben Amor
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

3.  Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs.

Authors:  Soumya D Chakravarty; Guofeng Zhu; Ming C Tsai; Vellore P Mohan; Simeone Marino; Denise E Kirschner; Luqi Huang; Joanne Flynn; John Chan
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

4.  Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.

Authors:  Xinxin Yang; Eugenie Dubnau; Issar Smith; Nicole S Sampson
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

5.  XDR-TB in South Africa: no time for denial or complacency.

Authors:  Jerome Amir Singh; Ross Upshur; Nesri Padayatchi
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.